Dose-dense ABVD as first-line therapy in early-stage unfavorable Hodgkin lymphoma: results of a prospective, multicenter double-step phase II study by Fondazione Italiana Linfomi

We investigated the feasibility and activity of an intensified dose-dense ABVD (dd-ABVD) regimen in patients with early-stage unfavorable Hodgkin lymphoma (HL). This prospective, multicenter, phase II study enrolled 96 patients with newly diagnosed, unfavorable stage I or II classical HL. The patien...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Annals of hematology 2021-10, Vol.100 (10), p.2547-2556
Hauptverfasser:	Santoro, Armando, Mazza, Rita, Spina, Michele, Califano, Catello, Specchia, Giorgina, Carella, Michele, Consoli, Ugo, Palombi, Francesca, Musso, Maurizio, Pulsoni, Alessandro, Kovalchuk, Sofya, Bonfichi, Maurizio, Ricci, Francesca, Fabbri, Alberto, Liberati, Anna Marina, Rodari, Marcello, Giordano, Laura, Chimienti, Emanuela, Balzarotti, Monica, Sorasio, Roberto, Gallamini, Andrea, Ghiggi, Chiara, Ciammella, Patrizia, Ricardi, Umberto, Chauvie, Stephane, Carlo-Stella, Carmelo, Merli, Francesco
Format:	Artikel
Sprache:	eng
Schlagworte:	Hematology Lymphoma Medicine Medicine & Public Health Oncology Original Article
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!